Back to News
Retail news

FDA Warns Bayer Over Aspirin Product Claims

The Food and Drug Administration has sent warning letters to Bayer claiming the company never submitted proof that its Women's Low Dose Aspirin + Calcium and Bayer Aspirin with Health Advantage are effective in treating heart disease or osteoporosis.

The RetailWire Daily

A daily briefing with the retail news, expert perspective, and business context to bring into your next meeting.

Want to know more? Learn more

Discussion Thread0